Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (16341)
All Articles published online
|
Publishing Process of This Article
|
Dec 28, 2018 (publication date) through Dec 25, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Wagner S, Mullins CS, Linnebacher M. Colorectal cancer vaccines: Tumor-associated antigens vs neoantigens. World J Gastroenterol 2018; 24(48): 5418-5432 [PMID: 30622371 DOI: 10.3748/wjg.v24.i48.5418] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v24/i48/5418.htm |
| Number | Citing Articles |
| 1 |
Zohreh Jahanafrooz, Behzad Baradaran, Jafar Mosafer, Mahmoud Hashemzaei, Tayebeh Rezaei, Ahad Mokhtarzadeh, Michael R. Hamblin. Comparison of DNA and mRNA vaccines against cancer. Drug Discovery Today 2020; 25(3): 552 doi: 10.1016/j.drudis.2019.12.003
|
| 2 |
Han Lin, Kun Wang, Yuxin Xiong, Liting Zhou, Yong Yang, Shanwei Chen, Peihong Xu, Yujun Zhou, Rui Mao, Guangzhao Lv, Peng Wang, Dong Zhou. Identification of Tumor Antigens and Immune Subtypes of Glioblastoma for mRNA Vaccine Development. Frontiers in Immunology 2022; 13 doi: 10.3389/fimmu.2022.773264
|
| 3 |
Chanchal Kumar, Rajat Pratap Singh, Mrigendra Kumar Dwiwedi, Ajay Amit. Colon Cancer Diagnosis and Therapy. 2021; : 271 doi: 10.1007/978-3-030-63369-1_14
|
| 4 |
Gary A. Piazza, Preethi Chandrasekaran, Yulia Y. Maxuitenko, Karim I. Budhwani. Assessment of KRASG12C inhibitors for colorectal cancer. Frontiers in Oncology 2024; 14 doi: 10.3389/fonc.2024.1412435
|
| 5 |
Yange Wang, Chenyang Li, Xinlei Qi, Yafei Yao, Lu Zhang, Guosen Zhang, Longxiang Xie, Qiang Wang, Wan Zhu, Xiangqian Guo. A Comprehensive Prognostic Analysis of Tumor-Related Blood Group Antigens in Pan-Cancers Suggests That SEMA7A as a Novel Biomarker in Kidney Renal Clear Cell Carcinoma. International Journal of Molecular Sciences 2022; 23(15): 8799 doi: 10.3390/ijms23158799
|
| 6 |
Yanwei Shen, Lu Yu, Xiaoli Xu, Shaojun Yu, Zhuo Yu. Neoantigen vaccine and neoantigen‐specific cell adoptive transfer therapy in solid tumors: Challenges and future directions. Cancer Innovation 2022; 1(2): 168 doi: 10.1002/cai2.26
|
| 7 |
Eirik Høye, Vegar J Dagenborg, Annette Torgunrud, Christin Lund-Andersen, Åsmund A Fretland, Susanne Lorenz, Bjørn Edwin, Eivind Hovig, Bastian Fromm, Else M Inderberg, Victor Greiff, Anne H Ree, Kjersti Flatmark. T cell receptor repertoire sequencing reveals chemotherapy-driven clonal expansion in colorectal liver metastases. GigaScience 2022; 12 doi: 10.1093/gigascience/giad032
|
| 8 |
Shu-Chang Nie, Yan-Hua Jing, Lu Lu, Si-Si Ren, Guang Ji, Han-Chen Xu. Mechanisms of myeloid-derived suppressor cell-mediated immunosuppression in colorectal cancer and related therapies. World Journal of Gastrointestinal Oncology 2024; 16(5): 1690-1704 doi: 10.4251/wjgo.v16.i5.1690
|
| 9 |
Thangavelu Soundara Rajan, Agnese Gugliandolo, Placido Bramanti, Emanuela Mazzon. In Vitro-Transcribed mRNA Chimeric Antigen Receptor T Cell (IVT mRNA CAR T) Therapy in Hematologic and Solid Tumor Management: A Preclinical Update. International Journal of Molecular Sciences 2020; 21(18): 6514 doi: 10.3390/ijms21186514
|
| 10 |
Charles M. Bowen, Krishna M. Sinha, Eduardo Vilar. Current Trends in Vaccine Development for Hereditary Colorectal Cancer Syndromes. Clinics in Colon and Rectal Surgery 2024; 37(03): 146 doi: 10.1055/s-0043-1770383
|
| 11 |
Shengnan Ren, Dingquan Yang, Yongli Dong, Weidong Ni, Meiqi Wang, Lei Xing, Tong Liu, Wenjia Hou, Weixuan Sun, Haolong Zhang, Zhentao Yu, Yi Liu, Jingrui Cao, Hongbo Yan, Ye Feng, Xuedong Fang, Quan Wang, Fangfang Chen. Protamine 1 as a secreted colorectal cancer-specific antigen facilitating G1/S phase transition under nutrient stress conditions. Cellular Oncology 2023; 46(2): 357 doi: 10.1007/s13402-022-00754-w
|
| 12 |
Ya‐Juan Zhu, Xiong Li, Ting‐Ting Chen, Jia‐Xiang Wang, Yi‐Xin Zhou, Xiao‐Li Mu, Yang Du, Jia‐Ling Wang, Jie Tang, Ji‐Yan Liu. Personalised neoantigen‐based therapy in colorectal cancer. Clinical and Translational Medicine 2023; 13(11) doi: 10.1002/ctm2.1461
|
| 13 |
A. Moeinafshar, S. Hemmati, N. Rezaei. Immunotherapy in AML: a brief review on emerging strategies. Clinical and Translational Oncology 2021; 23(12): 2431 doi: 10.1007/s12094-021-02662-1
|
| 14 |
Elena Tosti, Nityanand Srivastava, Winfried Edelmann. Vaccination and Microbiota Manipulation Approaches for Colon Cancer Prevention in Rodent Models. Cancer Prevention Research 2023; 16(8): 429 doi: 10.1158/1940-6207.CAPR-23-0015
|
| 15 |
Anil Kumar, Vipasha Gautam, Arushi Sandhu, Kajal Rawat, Antika Sharma, Lekha Saha. Current and emerging therapeutic approaches for colorectal cancer: A comprehensive review. World Journal of Gastrointestinal Surgery 2023; 15(4): 495-519 doi: 10.4240/wjgs.v15.i4.495
|
| 16 |
Haitao Wang, Rui Tang, Ling Jiang, Yingtian Jia. The role of PIK3CA gene mutations in colorectal cancer and the selection of treatment strategies. Frontiers in Pharmacology 2024; 15 doi: 10.3389/fphar.2024.1494802
|
| 17 |
Vladimir Roudko, Cansu Cimen Bozkus, Theofano Orfanelli, Christopher B. McClain, Caitlin Carr, Timothy O’Donnell, Lauren Chakraborty, Robert Samstein, Kuan-lin Huang, Stephanie V. Blank, Benjamin Greenbaum, Nina Bhardwaj. Shared Immunogenic Poly-Epitope Frameshift Mutations in Microsatellite Unstable Tumors. Cell 2020; 183(6): 1634 doi: 10.1016/j.cell.2020.11.004
|
| 18 |
Ka Lun Leung, Devika Verma, Younus Jamal Azam, Emyr Bakker. The use of multi-omics data and approaches in breast cancer immunotherapy: a review. Future Oncology 2020; 16(27): 2101 doi: 10.2217/fon-2020-0143
|
| 19 |
Simon N. Mbugua, Lydia W. Njenga, Ruth A. Odhiambo, Shem O. Wandiga, Martin O. Onani. Beyond DNA-targeting in Cancer Chemotherapy. Emerging Frontiers - A Review. Current Topics in Medicinal Chemistry 2021; 21(1): 28 doi: 10.2174/1568026620666200819160213
|
| 20 |
Stephen Jiang, David Good, Ming Q. Wei. Vaccinations for Colorectal Cancer: Progress, Strategies, and Novel Adjuvants. International Journal of Molecular Sciences 2019; 20(14): 3403 doi: 10.3390/ijms20143403
|
| 21 |
Ajay Prakash, Travis Gates, Xianda Zhao, Dechen Wangmo, Subbaya Subramanian. Tumor-derived extracellular vesicles in the colorectal cancer immune environment and immunotherapy. Pharmacology & Therapeutics 2023; 241: 108332 doi: 10.1016/j.pharmthera.2022.108332
|
| 22 |
Huanyou Sun, Wenwen Hu, Yinan Yan, Zichun Zhang, Yuxin Chen, Xuefan Yao, Ling Teng, Xinyuan Wang, Dafei Chai, Junnian Zheng, Gang Wang. Using PAMPs and DAMPs as adjuvants in cancer vaccines. Human Vaccines & Immunotherapeutics 2024; 17(12): 5546 doi: 10.1080/21645515.2021.1964316
|
| 23 |
Daniel Sur, Andrei Havasi, Calin Cainap, Gabriel Samasca, Claudia Burz, Ovidiu Balacescu, Iulia Lupan, Diana Deleanu, Alexandru Irimie. Chimeric Antigen Receptor T-Cell Therapy for Colorectal Cancer. Journal of Clinical Medicine 2020; 9(1): 182 doi: 10.3390/jcm9010182
|
| 24 |
Elżbieta Chruściel, Zuzanna Urban-Wójciuk, Łukasz Arcimowicz, Małgorzata Kurkowiak, Jacek Kowalski, Mateusz Gliwiński, Tomasz Marjański, Witold Rzyman, Wojciech Biernat, Rafał Dziadziuszko, Carla Montesano, Roberta Bernardini, Natalia Marek-Trzonkowska. Adoptive Cell Therapy—Harnessing Antigen-Specific T Cells to Target Solid Tumours. Cancers 2020; 12(3): 683 doi: 10.3390/cancers12030683
|
| 25 |
Rong Jiao, Xia Lin, Qian Zhang, Yan Zhang, Wen Qin, Qiaoling Yang, Chuan Xu, Fubo Chen, Kun Zhang. Anti-tumor immune potentiation targets-engineered nanobiotechnologies: Design principles and applications. Progress in Materials Science 2024; 142: 101230 doi: 10.1016/j.pmatsci.2023.101230
|
| 26 |
Qing Li, Shan Geng, Hao Luo, Wei Wang, Ya-Qi Mo, Qing Luo, Lu Wang, Guan-Bin Song, Jian-Peng Sheng, Bo Xu. Signaling pathways involved in colorectal cancer: pathogenesis and targeted therapy. Signal Transduction and Targeted Therapy 2024; 9(1) doi: 10.1038/s41392-024-01953-7
|
| 27 |
Lei Du, Qi Cheng, Hao Zheng, Jinming Liu, Lei Liu, Quan Chen. Targeting stemness of cancer stem cells to fight colorectal cancers. Seminars in Cancer Biology 2022; 82: 150 doi: 10.1016/j.semcancer.2021.02.012
|
| 28 |
Zheying Zhang, Manman Lu, Yu Qin, Wuji Gao, Li Tao, Wei Su, Jiateng Zhong. Neoantigen: A New Breakthrough in Tumor Immunotherapy. Frontiers in Immunology 2021; 12 doi: 10.3389/fimmu.2021.672356
|
| 29 |
Xiaoxue Xie, Ting Song, Yi Feng, Hanxi Zhang, Geng Yang, Chunhui Wu, Fengming You, Yiyao Liu, Hong Yang. Nanotechnology-based multifunctional vaccines for cancer immunotherapy. Chemical Engineering Journal 2022; 437: 135505 doi: 10.1016/j.cej.2022.135505
|
| 30 |
Shailesh Advani, Scott Kopetz. Ongoing and future directions in the management of metastatic colorectal cancer: Update on clinical trials. Journal of Surgical Oncology 2019; 119(5): 642 doi: 10.1002/jso.25441
|
| 31 |
Rani Chudasama, Quan Phung, Andrew Hsu, Khaldoun Almhanna. Vaccines in Gastrointestinal Malignancies: From Prevention to Treatment. Vaccines 2021; 9(6): 647 doi: 10.3390/vaccines9060647
|
| 32 |
Husham O Elzein. Association of Leukemia With ABO Blood Group Distribution and Discrepancy: A Review Article. Cureus 2024; doi: 10.7759/cureus.56812
|
| 33 |
Suman K. Ray, Yamini Meshram, Sukhes Mukherjee. Cancer Immunology and CAR-T Cells: A Turning Point Therapeutic Approach in Colorectal Carcinoma with Clinical Insight. Current Molecular Medicine 2021; 21(3): 221 doi: 10.2174/1566524020666200824103749
|
| 34 |
Nurul Ainaa Adilah Rus Bakarurraini, Nurul Syakima Ab Mutalib, Rahman Jamal, Nadiah Abu. The Landscape of Tumor-Specific Antigens in Colorectal Cancer. Vaccines 2020; 8(3): 371 doi: 10.3390/vaccines8030371
|
| 35 |
Guan‐Liang Chen, De‐Xia Kong, Yan Lin. Neo‐Antigen‐Reactive T Cells Immunotherapy for Colorectal Cancer: A More Personalized Cancer Therapy Approach. Global Challenges 2023; 7(11) doi: 10.1002/gch2.202200186
|
| 36 |
Kishwor Poudel, Tulasi Vithiananthan, Jong Oh Kim, Hensin Tsao. Recent progress in cancer vaccines and nanovaccines. Biomaterials 2025; 314: 122856 doi: 10.1016/j.biomaterials.2024.122856
|
| 37 |
Elham Sharif, Navid Nezafat, Elham Mohit. Recombinant ClearColi™-derived outer membrane vesicles as an effective carrier for development of neoepitope-based vaccine candidate against colon carcinoma. International Immunopharmacology 2024; 143: 113283 doi: 10.1016/j.intimp.2024.113283
|
| 38 |
Jingjing Song, Yujun Zhang, Chulin Zhou, Jianhao Zhan, Xifu Cheng, Haoyu Huang, Shengxun Mao, Zhen Zong. The dawn of a new Era: mRNA vaccines in colorectal cancer immunotherapy. International Immunopharmacology 2024; 132: 112037 doi: 10.1016/j.intimp.2024.112037
|
| 39 |
Danyang Wang, Hangyu Zhang, Tao Xiang, Gang Wang. Clinical Application of Adaptive Immune Therapy in MSS Colorectal Cancer Patients. Frontiers in Immunology 2021; 12 doi: 10.3389/fimmu.2021.762341
|
| 40 |
Julieann Puleo, Kornelia Polyak. A Darwinian perspective on tumor immune evasion. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 2022; 1877(1): 188671 doi: 10.1016/j.bbcan.2021.188671
|
| 41 |
Wenqing Jia, Tao Zhang, Haiyan Huang, Haoran Feng, Shaodong Wang, Zichao Guo, Zhiping Luo, Xiaopin Ji, Xi Cheng, Ren Zhao. Colorectal cancer vaccines: The current scenario and future prospects. Frontiers in Immunology 2022; 13 doi: 10.3389/fimmu.2022.942235
|
| 42 |
Georgios M. Stergiopoulos, Ianko Iankov, Evanthia Galanis. Personalizing Oncolytic Immunovirotherapy Approaches. Molecular Diagnosis & Therapy 2024; 28(2): 153 doi: 10.1007/s40291-023-00689-4
|
| 43 |
Ming Yi, Dechao Jiao, Shuang Qin, Qian Chu, Anping Li, Kongming Wu. Manipulating Gut Microbiota Composition to Enhance the Therapeutic Effect of Cancer Immunotherapy. Integrative Cancer Therapies 2019; 18 doi: 10.1177/1534735419876351
|
| 44 |
Jianpei Hu, Zengnan Mo. Dissection of tumor antigens and immune landscape in clear cell renal cell carcinoma: Preconditions for development and precision medicine of mRNA vaccine. Mathematical Biosciences and Engineering 2022; 20(2): 2157 doi: 10.3934/mbe.2023100
|
| 45 |
Mina Shahnazari, Pouria Samadi, Mona Pourjafar, Akram Jalali. Therapeutic vaccines for colorectal cancer: The progress and future prospect. International Immunopharmacology 2020; 88: 106944 doi: 10.1016/j.intimp.2020.106944
|
| 46 |
Alyssa Mauri Cornista, Maria Virginia Giolito, Kristi Baker, Hajar Hazime, Inès Dufait, Jashodeep Datta, Saratchandra Singh Khumukcham, Mark De Ridder, Jatin Roper, Maria T. Abreu, Karine Breckpot, Kevin Van der Jeught. Colorectal Cancer Immunotherapy: State of the Art and Future Directions. Gastro Hep Advances 2023; 2(8): 1103 doi: 10.1016/j.gastha.2023.09.007
|
| 47 |
Peter G. Alexander, Donald C. McMillan, James H. Park. The local inflammatory response in colorectal cancer – Type, location or density? A systematic review and meta-analysis. Cancer Treatment Reviews 2020; 83: 101949 doi: 10.1016/j.ctrv.2019.101949
|
| 48 |
Caitlin Boyne, Debra Lennox, Olivia Beech, Simon J. Powis, Pankaj Kumar. What Is the Role of HLA-I on Cancer Derived Extracellular Vesicles? Defining the Challenges in Characterisation and Potential Uses of This Ligandome. International Journal of Molecular Sciences 2021; 22(24): 13554 doi: 10.3390/ijms222413554
|
| 49 |
Jenna Cleyle, Marie-Pierre Hardy, Robin Minati, Mathieu Courcelles, Chantal Durette, Joel Lanoix, Jean-Philippe Laverdure, Krystel Vincent, Claude Perreault, Pierre Thibault. Immunopeptidomic Analyses of Colorectal Cancers With and Without Microsatellite Instability. Molecular & Cellular Proteomics 2022; 21(5): 100228 doi: 10.1016/j.mcpro.2022.100228
|
| 50 |
Ilene Le, Subramanian Dhandayuthapani, Jessica Chacon, Anna M. Eiring, Shrikanth S. Gadad. Harnessing the Immune System with Cancer Vaccines: From Prevention to Therapeutics. Vaccines 2022; 10(5): 816 doi: 10.3390/vaccines10050816
|
| 51 |
Sandra Schwarz, Johanna Schmitz, Markus W Löffler, Michael Ghosh, Hans-Georg Rammensee, Evgenia Olshvang, Marvin Markel, Nadine Mockel-Tenbrinck, Andrzej Dzionek, Susann Krake, Basak Arslan, Kapil Dev Kampe, Anne Wendt, Peter Bauer, Christina S Mullins, Andreas Schlosser, Michael Linnebacher. T cells of colorectal cancer patients’ stimulated by neoantigenic and cryptic peptides better recognize autologous tumor cells. Journal for ImmunoTherapy of Cancer 2022; 10(12): e005651 doi: 10.1136/jitc-2022-005651
|
| 52 |
Andreia Bufalino. Pathological Basis of Oral and Maxillofacial Diseases. 2025; : 429 doi: 10.1002/9781119989233.ch25
|
| 53 |
Zohreh Jahanafrooz, Fatemeh Oroojalian, Ahad Mokhtarzadeh, Abbas Rahdar, Ana M. Díez‐Pascual. Nanovaccines: Immunogenic tumor antigens, targeted delivery, and combination therapy to enhance cancer immunotherapy. Drug Development Research 2024; 85(5) doi: 10.1002/ddr.22244
|
| 54 |
Yae Kye, Lokesh Nagineni, Shrikanth Gadad, Fabiola Ramirez, Hannah Riva, Lorena Fernandez, Michelle Samaniego, Nathan Holland, Rose Yeh, Kei Takigawa, Subramanian Dhandayuthapani, Jessica Chacon. The Identification and Clinical Applications of Mutated Antigens in the Era of Immunotherapy. Cancers 2022; 14(17): 4255 doi: 10.3390/cancers14174255
|
| 55 |
Hajar Rajayi, Parsova Tavasolian, Alaleh Rezalotfi, Marzieh Ebrahimi. Cancer Stem Cells Targeting; the Lessons from the Interaction of the Immune System, the Cancer Stem Cells and the Tumor Niche. International Reviews of Immunology 2019; 38(6): 267 doi: 10.1080/08830185.2019.1669593
|
| 56 |
Lynne W. Elmore, Susanna F. Greer, Elvan C. Daniels, Charles C. Saxe, Michael H. Melner, Ginger M. Krawiec, William G. Cance, William C. Phelps. Blueprint for cancer research: Critical gaps and opportunities. CA: A Cancer Journal for Clinicians 2021; 71(2): 107 doi: 10.3322/caac.21652
|
| 57 |
Jiahui Zhang, Jingyi Fan, Mariusz Skwarczynski, Rachel J Stephenson, Istvan Toth, Waleed M Hussein. Peptide-Based Nanovaccines in the Treatment of Cervical Cancer: A Review of Recent Advances. International Journal of Nanomedicine 2022; : 869 doi: 10.2147/IJN.S269986
|
| 58 |
Sang-Hyun Kim, Ha-Eun Park, Seong-Un Jeong, Jun-Hyeok Moon, Young-Ran Lee, Jeong-Ki Kim, Hyunseok Kong, Chan-Su Park, Chong-Kil Lee. Induction of Peptide-specific CTL Activity and Inhibition of Tumor Growth Following Immunization with Nanoparticles Coated with Tumor Peptide-MHC-I Complexes. Immune Network 2021; 21(6) doi: 10.4110/in.2021.21.e44
|
| 59 |
Ana Montero-Calle, María Garranzo-Asensio, Maria Teresa Moreno-Casbas, Susana Campuzano, Rodrigo Barderas. Autoantibodies in cancer: a systematic review of their clinical role in the most prevalent cancers. Frontiers in Immunology 2024; 15 doi: 10.3389/fimmu.2024.1455602
|
| 60 |
Anping Li, Ming Yi, Shuang Qin, Qian Chu, Suxia Luo, Kongming Wu. Prospects for combining immune checkpoint blockade with PARP inhibition. Journal of Hematology & Oncology 2019; 12(1) doi: 10.1186/s13045-019-0784-8
|
| 61 |
Qianli Ye, Shixing Liu, Shiqiang Lin, Wen Xie. Circular RNA circSEMA5A facilitates colorectal cancer development by regulating microRNA-195-5p to target CCNE1 axis. Cellular Signalling 2023; 107: 110649 doi: 10.1016/j.cellsig.2023.110649
|
| 62 |
Xiaofei Zhang, Qin Hu, Xuesong He, Xinyue Cui, Zhaoyuan Liang, Li Wang, Xiongwei Deng, Ze Zhang, Wang Sheng, Xiaodong D. Han. CD16 CAR-T cells enhance antitumor activity of CpG ODN-loaded nanoparticle-adjuvanted tumor antigen-derived vaccinevia ADCC approach. Journal of Nanobiotechnology 2023; 21(1) doi: 10.1186/s12951-023-01900-8
|
| 63 |
Kun Wang, Tong Zhang, Mingyang Liu, Danyang Wang, Haomiao Zhu, Zhaoyu Wang, Fan Yu, Yonghui Liu, Wei Zhao. Synthesis and immunological evaluation of Mincle ligands-based antitumor vaccines. Chinese Chemical Letters 2023; 34(7): 108065 doi: 10.1016/j.cclet.2022.108065
|
| 64 |
Weijie Ma, Brian Pham, Tianhong Li. Cancer neoantigens as potential targets for immunotherapy. Clinical & Experimental Metastasis 2022; 39(1): 51 doi: 10.1007/s10585-021-10091-1
|
| 65 |
Sung-Woo Lee, He Yun Choi, Gil-Woo Lee, Therasa Kim, Hyun-Ju Cho, In-Jae Oh, Sang Yun Song, Deok Hwan Yang, Jae-Ho Cho. CD8+ TILs in NSCLC differentiate into TEMRA via a bifurcated trajectory: deciphering immunogenicity of tumor antigens. Journal for ImmunoTherapy of Cancer 2021; 9(9): e002709 doi: 10.1136/jitc-2021-002709
|
| 66 |
Cristina Aparicio, Marina Belver, Lucía Enríquez, Francisco Espeso, Lucía Núñez, Ana Sánchez, Miguel Ángel de la Fuente, Margarita González-Vallinas. Cell Therapy for Colorectal Cancer: The Promise of Chimeric Antigen Receptor (CAR)-T Cells. International Journal of Molecular Sciences 2021; 22(21): 11781 doi: 10.3390/ijms222111781
|
| 67 |
Li-Feng Hu, Huan-Rong Lan, Dong Huang, Xue-Min Li, Ke-Tao Jin. Personalized Immunotherapy in Colorectal Cancers: Where Do We Stand?. Frontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.769305
|
| 68 |
|
| 69 |
Alaa Alsalloum, Julia Shevchenko, Sergey Sennikov. The Melanoma-Associated Antigen Family A (MAGE-A): A Promising Target for Cancer Immunotherapy?. Cancers 2023; 15(6): 1779 doi: 10.3390/cancers15061779
|
| 70 |
Yuanfang Tan, Huiyuan Chen, Xi Gou, Qiuying Fan, Juanjuan Chen. Tumor vaccines: Toward multidimensional anti-tumor therapies. Human Vaccines & Immunotherapeutics 2023; 19(3) doi: 10.1080/21645515.2023.2271334
|
| 71 |
Carlos A. Gonzalez-Villarreal, Adriana G. Quiroz-Reyes, Jose F. Islas, Elsa N. Garza-Treviño. Colorectal Cancer Stem Cells in the Progression to Liver Metastasis. Frontiers in Oncology 2020; 10 doi: 10.3389/fonc.2020.01511
|
| 72 |
Aaron T. Ciner, Keaton Jones, Ruth J. Muschel, Pnina Brodt. The unique immune microenvironment of liver metastases: Challenges and opportunities. Seminars in Cancer Biology 2021; 71: 143 doi: 10.1016/j.semcancer.2020.06.003
|
| 73 |
Mohammad Roufarshbaf, Nafiseh Esmaeil, Vajihe Akbari. Comparison of four methods of colon cancer cell lysates preparation for ex vivo maturation of dendritic cells. Research in Pharmaceutical Sciences 2022; 17(1): 43 doi: 10.4103/1735-5362.329925
|
| 74 |
Evangelos Koustas, Eleni-Myrto Trifylli, Panagiotis Sarantis, Nikolaos Papadopoulos, Eleni Karapedi, Georgios Aloizos, Christos Damaskos, Nikolaos Garmpis, Anna Garmpi, Kostas A. Papavassiliou, Michalis V. Karamouzis, Athanasios G. Papavassiliou. Immunotherapy as a Therapeutic Strategy for Gastrointestinal Cancer—Current Treatment Options and Future Perspectives. International Journal of Molecular Sciences 2022; 23(12): 6664 doi: 10.3390/ijms23126664
|
| 75 |
Wenjing Cai, Tuyue Sun, Chenyu Qiu, Huixiang Sheng, Ruijie Chen, Congying Xie, Longfa Kou, Qing Yao. Stable triangle: nanomedicine-based synergistic application of phototherapy and immunotherapy for tumor treatment. Journal of Nanobiotechnology 2024; 22(1) doi: 10.1186/s12951-024-02925-3
|
| 76 |
Rajasekaran Subbarayan, Dhasarathdev Srinivasan, Ranjith Balakrishnan, Ajeet Kumar, Salman Sadullah Usmani, Nityanand Srivastava. Targeting Signaling Pathways in Solid Tumors - Part C. International Review of Cell and Molecular Biology 2024; 389: 104 doi: 10.1016/bs.ircmb.2024.05.001
|
| 77 |
Liu Chuang, Ju Qifeng, Yu Shaolei. The tumor immune microenvironment and T-cell-related immunotherapies in colorectal cancer. Discover Oncology 2024; 15(1) doi: 10.1007/s12672-024-01117-7
|
| 78 |
Wenli Fang, Zhangyan Jing, Yuan Li, Zhirang Zhang, Zhongda Lin, Zhaoxin Yang, Yishi Tian, Chi Zhang, Yumeng Ma, Linlin Hou, Fanqiang Meng, Xin Liang, Xudong Zhang. Harnessing enucleated cancer cells as Trojan horse cell vaccines. Cell Reports Physical Science 2024; 5(1): 101752 doi: 10.1016/j.xcrp.2023.101752
|
| 79 |
Liguo Ye, Long Wang, Ji’an Yang, Ping Hu, Chunyu Zhang, Shi’ao Tong, Zhennan Liu, Daofeng Tian. Identification of tumor antigens and immune subtypes in lower grade gliomas for mRNA vaccine development. Journal of Translational Medicine 2021; 19(1) doi: 10.1186/s12967-021-03014-x
|
| 80 |
Liguo Ye, Long Wang, Ji’an Yang, Ping Hu, Chunyu Zhang, Shi’ao Tong, Zhennan Liu, Daofeng Tian. Identification of Tumor Antigens and Immune Landscape in Glioblastoma for mRNA Vaccine Development. Frontiers in Genetics 2021; 12 doi: 10.3389/fgene.2021.701065
|
| 81 |
Azar Dokht Khosravi, Sakineh Seyed-Mohammadi, Ali Teimoori, Aram Asarehzadegan Dezfuli. The role of microbiota in colorectal cancer. Folia Microbiologica 2022; 67(5): 683 doi: 10.1007/s12223-022-00978-1
|
| 82 |
Jinfeng Chen, Ziqi Jin, Shuqing Zhang, Xiao Zhang, Peipei Li, Heng Yang, Yuting Ma. Arsenic trioxide elicits prophylactic and therapeutic immune responses against solid tumors by inducing necroptosis and ferroptosis. Cellular & Molecular Immunology 2022; 20(1): 51 doi: 10.1038/s41423-022-00956-0
|
| 83 |
Sofian Al Shboul, Ashita Singh, Renata Kobetic, David R. Goodlett, Paul M. Brennan, Ted Hupp, Irena Dapic. Mass Spectrometry Advances in Analysis of Glioblastoma. Mass Spectrometry Reviews 2024; doi: 10.1002/mas.21912
|
| 84 |
Dorothea Plundrich, Sophia Chikhladze, Stefan Fichtner-Feigl, Reinhild Feuerstein, Priscilla S. Briquez. Molecular Mechanisms of Tumor Immunomodulation in the Microenvironment of Colorectal Cancer. International Journal of Molecular Sciences 2022; 23(5): 2782 doi: 10.3390/ijms23052782
|
| 85 |
Salima Shebbo, Najat Binothman, Manar Darwaish, Hanan A. Niaz, Rwaa H. Abdulal, Jamilah Borjac, Anwar M. Hashem, Ahmad Bakur Mahmoud. Redefining the battle against colorectal cancer: a comprehensive review of emerging immunotherapies and their clinical efficacy. Frontiers in Immunology 2024; 15 doi: 10.3389/fimmu.2024.1350208
|
| 86 |
Shougen Cao, Wenyu Jia, Yifan Zhao, Heng Liu, Jie Cao, Zequn Li. A recent perspective on designing tumor vaccines for tumor immunology. International Immunopharmacology 2024; 142: 113090 doi: 10.1016/j.intimp.2024.113090
|